Clinical Expertise: Pancreatic,
Liver, Gallbladder, and Reflux Disease, Minimally Invasive
Surgical Approaches to the Esophagus and Liver (Both
Benign and Malignant Diseases), Reoperative Surgery
Medical Education: Harvard Medical
School, Boston
Residency: Mount Sinai Medical Center,
New York
Fellowship: Surgical Critical Care/Trauma,
Jackson Memorial Hospital, University of Miami School
of Medicine
Board Certification: General Surgery,
Surgical Critical Care
Professional Affiliations: American College of Surgeons, American Hepato Pancreato Biliary Association (AHPBA), Society of Surgical Oncology, American College of Surgeons Oncology Group (ACOSOG), American Association for the Surgery of Trauma, Association of Program Directors in Surgery (APDS)
Research Interests: Acute pancreatitis global consensus definition statement and EBM, ACOSOG E2202, Minimally Invasive Esophagectomy: A Multicenter Feasibility Study, An intergroup randomized phase II study of bevacizumab or cetuximab in combination with gemcitabine and in combination with chemoradiation in patients with completely resected pancreatic carcinoma, Neoadjuvant chemoradiation with oxaliplatin and capecitabine for patients with surgically respectable gastric cancer, Oxaliplatin plus protracted 5 fu and radiation for potentially curable esophageal cancer: A phase II trial with molecular correlates, Phase III randomized double blind study of adjuvant ST1571 versus placebo in patients following the resection of primary gastrointestinal stromal tumors, Flexible transgastric peritoneoscopy: feasibility and applicability in large animal model.
Meet other members of the surgical oncology team.
|
